AR066710A1 - Derivados de espirociclopropilpiperidina - Google Patents
Derivados de espirociclopropilpiperidinaInfo
- Publication number
- AR066710A1 AR066710A1 ARP080102192A ARP080102192A AR066710A1 AR 066710 A1 AR066710 A1 AR 066710A1 AR P080102192 A ARP080102192 A AR P080102192A AR P080102192 A ARP080102192 A AR P080102192A AR 066710 A1 AR066710 A1 AR 066710A1
- Authority
- AR
- Argentina
- Prior art keywords
- substituted
- alkyl
- cycloalkyl
- aryl
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Immunology (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Physical Education & Sports Medicine (AREA)
- Communicable Diseases (AREA)
- Psychology (AREA)
- Diabetes (AREA)
- Transplantation (AREA)
- Hospice & Palliative Care (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Child & Adolescent Psychology (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Anesthesiology (AREA)
- AIDS & HIV (AREA)
Abstract
Una composicion farmacéutica que comprende un derivado de piperidina descrito aquí, y un método para usar un derivado de piperidina descrito aquí para tratar una afeccion asociada con el receptor H3 de histamina. Reivindicacion 1: Un compuesto de formula (1), enantiomeros del mismo, sales farmacéuticamente aceptables del mismo, o mezclas del mismo, en la que: R1 es arilo, heteroarilo, arilalquilo, heteroarilalquilo, cicloalquilo, heterocicloalquilalquilo, alquilo, alcoxialquilo, hidroxialquilo, aminoalquilo, aminocarbonilalquilo, heterociclo, arilalquenilo, o heterocicloalquilo; en la que R1 está opcionalmente sustituido con al menos un sustituyente seleccionado independientemente de alquilo, ciano, sulfinilo, haloalquilo, amida, alcoxi, halogeno, arilalcoxi, alquilcarbonilo, carboxi (-C(=O)OH), hidroxi (-OH), amino, alcoxicarbonilo, y alquilsulfonilo; y R2 es arilo, heteroarilo, cicloalquilo, alquilo, heterocicloalquilo, o cicloalquilalquilo; en la que R2 está opcionalmente sustituido con al menos un sustituyente seleccionado independientemente de alquilo C1-6, alcoxi, y cicloalquilo; con las condiciones de que: 1) cuando R2 es un ciclohexilo, R1 no sea un fenilo sustituido o no sustituido; 2) cuando R2 es arilo, R2 no sea un fenilo no sustituido; y 3) cuando R1 es tetrahidropiran-4-ilo y R2 es un fenilo sustituido, el fenilo sustituido no esté sustituido en orto o en meta con metilo ni esté sustituido en meta con metoxi.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94035007P | 2007-05-25 | 2007-05-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR066710A1 true AR066710A1 (es) | 2009-09-09 |
Family
ID=40075371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080102192A AR066710A1 (es) | 2007-05-25 | 2008-05-23 | Derivados de espirociclopropilpiperidina |
Country Status (20)
Country | Link |
---|---|
US (1) | US20100168105A1 (es) |
EP (1) | EP2162452A4 (es) |
JP (1) | JP2010527998A (es) |
KR (1) | KR20100020452A (es) |
CN (1) | CN101754963A (es) |
AR (1) | AR066710A1 (es) |
AU (1) | AU2008257614A1 (es) |
BR (1) | BRPI0811238A2 (es) |
CA (1) | CA2688375A1 (es) |
CL (1) | CL2008001506A1 (es) |
CO (1) | CO6241111A2 (es) |
EC (1) | ECSP099754A (es) |
IL (1) | IL202019A0 (es) |
MX (1) | MX2009012427A (es) |
PE (1) | PE20090295A1 (es) |
RU (1) | RU2009143103A (es) |
TW (1) | TW200902007A (es) |
UY (1) | UY31100A1 (es) |
WO (1) | WO2008147314A1 (es) |
ZA (1) | ZA200907865B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1272204E (pt) | 2000-04-14 | 2007-10-02 | Univ Pittsburgh | Aumento e enchimento de tecidos moles e osso utilizando células progenitoras derivadas de músculo, suas composições e tratamentos |
WO2009071668A2 (en) | 2007-12-05 | 2009-06-11 | Biovitrum Ab (Publ) | Piperazine derivatives and their use as leptin receptor modulators |
US20100130477A1 (en) * | 2008-11-25 | 2010-05-27 | Astrazeneca Ab | Spirocyclobutyl Piperidine Derivatives |
CN105820120B (zh) * | 2016-03-25 | 2019-01-22 | 上海博栋化学科技有限公司 | 具有生物活性的6-氮杂螺[2,5]辛烷类化合物及其制备方法和应用 |
BR112018068538B1 (pt) * | 2016-03-31 | 2023-12-12 | Takeda Pharmaceutical Company Limited | Composto, medicamento, e, uso de um composto |
US20220119351A1 (en) * | 2019-05-02 | 2022-04-21 | Merck Sharp & Dohme Corp. | Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors |
KR102227224B1 (ko) | 2019-07-23 | 2021-03-11 | 한국섬유개발연구원 | 유연성을 갖는 엘이디 섬유원단 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL128928A0 (en) * | 1996-09-13 | 2000-02-17 | Schering Corp | Tricyclic inhibitors of farnesyl protein transferase |
JP4527408B2 (ja) * | 2002-04-26 | 2010-08-18 | シェーリング コーポレイション | ムスカリン性アンタゴニスト |
BRPI0409611A (pt) * | 2003-04-23 | 2006-04-18 | Glaxo Group Ltd | derivados de piperazina e uso dos mesmos para o tratamento de doenças neurológicas e psiquiátricas |
DE602005005080T2 (de) * | 2004-10-15 | 2009-02-26 | Glaxo Group Ltd., Greenford | Pyrrolidinderivate als histaminrezeptor-liganden |
CA2606004A1 (en) * | 2005-08-02 | 2007-02-08 | Neurogen Corporation | Dipiperazinyl ketones and related analogues |
-
2008
- 2008-05-21 TW TW097118720A patent/TW200902007A/zh unknown
- 2008-05-22 UY UY31100A patent/UY31100A1/es unknown
- 2008-05-23 US US12/601,308 patent/US20100168105A1/en not_active Abandoned
- 2008-05-23 BR BRPI0811238-0A2A patent/BRPI0811238A2/pt not_active Application Discontinuation
- 2008-05-23 CL CL2008001506A patent/CL2008001506A1/es unknown
- 2008-05-23 KR KR1020097024457A patent/KR20100020452A/ko not_active Application Discontinuation
- 2008-05-23 CN CN200880025362A patent/CN101754963A/zh active Pending
- 2008-05-23 AR ARP080102192A patent/AR066710A1/es unknown
- 2008-05-23 EP EP08754002A patent/EP2162452A4/en not_active Withdrawn
- 2008-05-23 WO PCT/SE2008/050606 patent/WO2008147314A1/en active Application Filing
- 2008-05-23 MX MX2009012427A patent/MX2009012427A/es unknown
- 2008-05-23 JP JP2010509303A patent/JP2010527998A/ja active Pending
- 2008-05-23 RU RU2009143103/04A patent/RU2009143103A/ru unknown
- 2008-05-23 PE PE2008000891A patent/PE20090295A1/es not_active Application Discontinuation
- 2008-05-23 CA CA002688375A patent/CA2688375A1/en not_active Abandoned
- 2008-05-23 AU AU2008257614A patent/AU2008257614A1/en not_active Abandoned
-
2009
- 2009-11-09 ZA ZA200907865A patent/ZA200907865B/xx unknown
- 2009-11-09 IL IL202019A patent/IL202019A0/en unknown
- 2009-11-11 CO CO09128426A patent/CO6241111A2/es not_active Application Discontinuation
- 2009-11-23 EC EC2009009754A patent/ECSP099754A/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2010527998A (ja) | 2010-08-19 |
CN101754963A (zh) | 2010-06-23 |
EP2162452A1 (en) | 2010-03-17 |
CA2688375A1 (en) | 2008-12-04 |
US20100168105A1 (en) | 2010-07-01 |
RU2009143103A (ru) | 2011-06-27 |
CL2008001506A1 (es) | 2008-11-28 |
IL202019A0 (en) | 2010-06-16 |
BRPI0811238A2 (pt) | 2014-11-11 |
MX2009012427A (es) | 2009-12-01 |
WO2008147314A1 (en) | 2008-12-04 |
PE20090295A1 (es) | 2009-04-01 |
TW200902007A (en) | 2009-01-16 |
AU2008257614A1 (en) | 2008-12-04 |
CO6241111A2 (es) | 2011-01-20 |
KR20100020452A (ko) | 2010-02-22 |
EP2162452A4 (en) | 2012-02-29 |
ECSP099754A (es) | 2009-12-28 |
ZA200907865B (en) | 2010-07-28 |
UY31100A1 (es) | 2009-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR066710A1 (es) | Derivados de espirociclopropilpiperidina | |
ES2668775T3 (es) | Compuestos tetracíclicos | |
BRPI0810929B8 (pt) | uso de um composto de fórmula 1 | |
CO6260132A2 (es) | Derivados de oxadiazol como inhibidores de dgat | |
AR054024A1 (es) | Derivados de piridina -3- carboxamida como agonistas inversos de cb1 | |
AR078163A1 (es) | Utilizacion de aminodihidrotiazinas para el tratamiento o prevencion de la diabetes | |
UY32417A (es) | Compuestos de piridazinona | |
DK2069374T3 (da) | Krystallinske solvater af (1s)-1,5-anhydro-1-c-(3-((phenyl) methyl)phenyl)-d-glucitolderivater med alkoholer som sglt2-inhibitorer til behandling af diabetes | |
PE20080140A1 (es) | DERIVADOS DE CINAMIDA MULTICICLICOS COMO INHIBIDORES DE ß AMILOIDE | |
AR086474A1 (es) | Compuestos de pirazol pesticidas | |
AR068764A1 (es) | N-piperazin amidas y su uso en medicamentos para el tratamiento de enfermedades mediadas por la inhibicion de faah. | |
ECSP067124A (es) | Inhibidores de cetp | |
AR059094A1 (es) | Derivados de ciclohexil - sulfonamida | |
EA201101334A1 (ru) | Новые соединения бензотиадиазепина, способ их приготовления и фармацевтические композиции, содержащие их | |
AR049276A1 (es) | Compuestos carboxamidos opiodes y composiciones farmaceuticas que los contienen | |
MX2010001170A (es) | Derivados de imidazolona, metodo de preparacion de los mismos y uso biologico de los mismos. | |
DK2125736T3 (da) | Substituerede acetophenoner egnede som PDE4-inhibitorer | |
PE20151281A1 (es) | Derivados de ciclopropilamida dirigidos contra el receptor de histamina h3 | |
EA200700758A1 (ru) | Новые производные бис-азаиндолов, их получение и фармацевтическое применение в качестве ингибиторов киназ | |
CR9432A (es) | Derivado de bencimidazol y uso como antagonista de angiotensina ii | |
EA201071012A1 (ru) | Производные азетидинов, способ их получения и применение их в терапии | |
AR057197A1 (es) | Derivados de 1, 1-dioxo-tiomorfolinil-indolil-metanona | |
AR062769A1 (es) | Derivados de 5- fenil- nicotilamida | |
AR053141A1 (es) | Imidazoles sustituidos con heterociclilamida | |
BRPI0910761A2 (pt) | compostos tendo atividade antagonista de receptores npy y5 e composições farmacêuticas compreendendo os mesmos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |